Aug. 6, 2024
by Roman Kasianov
News
Researchers at UCLA Health's Jonsson Comprehensive Cancer Center have launched a pioneering clinical trial to evaluate the safety and efficacy …
Aug. 5, 2024
by Roman Kasianov
News
Lantern Pharma has announced positive preliminary results from the ongoing Phase 2 HARMONIC clinical trial, targeting never smokers with advanced …
July 29, 2024
by Andrii Buvailo, PhD
Biopharma insight
A clinical trial of a novel off-the-shelf stem cell therapy for knee osteoarthritis has shown significant improvements in pain relief …
July 29, 2024
by Andrii Buvailo
News
BioAge Labs, Inc. has announced the dosing of the first patient in the STRIDES Phase 2 clinical trial. This study …
July 24, 2024
by Roman Kasianov
News
Advarra has introduced new functionality to centralize patient recruitment activities within its Longboat platform. This enhancement aims to provide sponsors …
July 22, 2024
by BiopharmaTrend
News
A novel initiative by Medical and Commercial International Limited (MCI) and GATC Health Corp, supported by Lloyd's of London, promises …
July 10, 2024
by Roman Kasianov
News
Concr has initiated the recruitment of patients for the VISION trial, an observational clinical study designed to evaluate Concr's predictive …
June 17, 2024
by Andrii Buvailo, PhD
News
Yonalink, a Boston-based provider of EHR-to-EDC streaming solutions for clinical trials, has announced the successful completion of its largest live …
June 12, 2024
by Roman Kasianov
News
Lantern Pharma Inc., an AI-driven company focused on oncology drug development, has announced that the Japan Patent Office (JPO) has granted …
June 11, 2024
by Roman Kasianov
News
Lokavant has unveiled Spectrum, an AI software solution designed to enhance clinical trial feasibility and optimization throughout the entire clinical …
June 6, 2024
by Roman Kasianov
News
The Food and Drug Administration (FDA) and CluePoints, a provider of statistical and AI-driven software solutions, have entered a new …
May 30, 2024
by Roman Kasianov
News
Insmed Incorporated has reported positive topline results from the ASPEN study, a pivotal Phase III clinical trial evaluating the efficacy, …